We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

45 hedge funds and large institutions have $7.66M invested in BioPlus Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more capital invested

Capital invested by funds: $2.99M → $7.66M (+$4.67M)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

8% less funds holding

Funds holding: 49 → 45 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
7
Calls
$1.97M
Puts
–
Net Calls
+$1.97M
Net Calls Change
+$13K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$25.6K
2
MP
Mangrove Partners
Connecticut
+$18.9K
3
PC
Periscope Capital
Ontario, Canada
+$6.72K
4
LP
LMR Partners
United Kingdom
+$6.39K
5
CAC
Cowen and Company
New York
+$1.43K

Top Sellers

Rank Fund Capital Flow
1
RA
Ramius Advisors
New York
-$16K
2
MF
Magnetar Financial
Illinois
-$14K
3
AGM
Alpine Global Management
New York
-$5K
4
BCM
Basso Capital Management
Connecticut
-$2K
5
TI
Tidal Investments
Wisconsin
-$2K

BIOSW Hedge Fund Activity: Q4 2022 in Review

45 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q4 2022, worth a combined $7.66M — up 156% from $2.99M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BIOSW and 3 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $25.6K. The largest seller was Ramius Advisors, exiting entirely with an estimated $16K sold.

  • 45 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q4 2022, down from 49 in Q3 2022.
  • Funds reported $7.66M of BioPlus Acquisition Corp. Warrants stock for Q4 2022, up 156% quarter-over-quarter.
  • 3 funds opened new BioPlus Acquisition Corp. Warrants positions in Q4 2022 and 7 closed out, a net change of -4 holders.
  • The largest BioPlus Acquisition Corp. Warrants buyer in Q4 2022 was Calamos Advisors, an estimated $25.6K added.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q4 2022 was Ramius Advisors, an estimated $16K sold.

Based on aggregated 13F filings for Q4 2022.